Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1859)	8/8/2007 2:35:58 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

RIGL Is up 19.45%. The stock is up for 2nd day on a roll & it is now trading above its Jul20 H of 9.36 bigcharts.marketwatch.com Although its 2ndQ loss was $19.2M ($0.68/shr)vs. $2.3M ($0.09/shr)in 2006. The previous Yr. results included milestone payments from PFE & MRK for around $10M & operating expenses in 2007 were $5M > in 2006. As of June 30,RIGL had cash of approximately $126.5M vs.$88.6M in March & $104.5M in December, since in the 2ndQ it completed a public offering of 5,750,000 shares at $9.75 (with net proceeds of $52.3M). Last month MRK started a PI of R763 in patients with advanced malignancies & in a PII of R788 in patients with ITP, it sowed encouraging preliminary results,raising the platelet counts in several of the patients. RIGL Is expected to continue to have heavy losses in 2007 & 2008.It seems to have significant resistance at th3 $12 level, before it can start closing some of its DG of December 2005. bigcharts.marketwatch.com Bernard